BLVRB Redox Mutation Defines Heme Degradation in a Metabolic Pathway of Enhanced Thrombopoiesis in Humans.

Song Wu,Zongdong Li,Dmitri V. Gnatenko,Beibei Zhang,Lu Zhao,Lisa E. Malone,Nedialka Markova,Timothy J. Mantle,Natasha M. Nesbitt,Wadie F. Bahou
DOI: https://doi.org/10.1182/blood-2016-02-696997
IF: 20.3
2016-01-01
Blood
Abstract:Key PointsA biliverdin IXβ reductase redox coupling mutation with associated ROS dysregulation has been identified in thrombocytosis cohorts. Defective BLVRB enzymatic activity involving heme degradation pathway alters metabolic consequences of hematopoietic lineage fate.
What problem does this paper attempt to address?